临床特征和治疗疗效的同时发病的失眠和睡眠呼吸暂停 (COMISA):从定性和定量分析的证据
Jie Liu1,2,3, Chenyang Zang1,2,3, Minhan Yi4
1Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Behavioral sleep medicine
|March 22, 2024
概括
同病性失眠和睡眠呼吸暂停 (COMISA) 显著恶化睡眠质量,增加精神和心血管疾病的风险. 将失眠认知行为疗法 (CBTI) 与正气道压力 (PAP) 疗法相结合,可以改善COMISA症状.
科学领域:
- 睡眠医学 睡眠医学
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
背景情况:
- 同病性失眠和睡眠呼吸暂停 (COMISA) 给身体和精神健康带来了重大挑战.
- 关于COMISA临床特征和管理的定量证据有限.
研究的目的:
- 为了研究COMISA的临床特征.
- 评估COMISA的管理策略.
主要方法:
- 进行了系统的文献检索,选择和质量评估.
- 权重平均差异 (WMD) 和几率比率 (OR) 用于分析睡眠特征,并发症和治疗结果.
- 结果包括睡眠健康参数和身体/精神健康障碍.
主要成果:
- 与单独的OSA或失眠患者相比,COMISA患者的睡眠质量较差,睡眠碎片化增加.
- COMISA与患抑郁症,PTSD,心血管疾病,高血压和糖尿病的风险更高有关.
- 对失眠的综合认知行为疗法 (CBTI) 和正气道压力 (PAP) 疗法改善了失眠的严重程度和睡眠效率,远远超过单独使用PAP.
结论:
- COMISA对睡眠质量和结构产生负面影响,增加心脏代谢和精神疾病的风险.
- 结合CBTI和PAP治疗是改善COMISA患者睡眠障碍的推治疗方法.
相关概念视频
Sleep Apnea
149
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
149
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Insomnia
85
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
85
Sleepwalking and Sleep Talking
158
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
158
Narcolepsy
102
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
102
Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171


